◆ 会议时间：2025年2月21-23日
◆ 会议地点：新加坡（Singapore）

◆ 会议简介：

2025年第13届亚太乳腺癌峰会(APBCS)将于2025年2月21-23日在新加坡举行。

13th Asia Pacific Breast Cancer Summit (APBCS 2025)

Date: 21 -23 February, 2025
Venue: Grand Hyatt, Singapore

摘要征文投稿：

Key Dates

• 10 NOVEMBER, 2024 : Submission of Abstracts Closes
• 18 NOVEMBER, 2024 : Applicants Notified of Abstract Acceptance
• 30 NOVEMBER, 2024 : Deadline for Registration of Abstract Presenters

点此提交摘要>>>Submit Abstract>>>

Esteemed Colleagues and Friends,

Warm greetings,

Asia Pacific Breast Cancer Summit (APBCS) over the years has evolved into a premiere platform in the field of breast cancer management in the Asia-Pac region for over 13 years. Our scientific and organizing committee are relentlessly working towards bringing the best global, regional, and local experts and research to enhance the patient care, aligning to its theme, “Patient Advocacy and Integrative Medicine”.

The impact of APBCS has been resounding in various APAC region, and Singapore marks the next chapter in the journey for its 13th edition in 2025. The scientific and organizing committee of APBCS 2025 edition would like to extend a warm welcome to each one of you from 21st to 23rd February, 2025 at Grand Hyatt, Singapore.

APBCS 2025 edition will feature stellar key opinion leaders from across the globe to share insights in the realm of Breast Cancer. Over 3 days, the agenda will include Surgical Workshop, Oncology Nursing Session, Patient Advocacy, Integrative Medicine Session, Best of San Antonio Breast Cancer Symposium Review, and in-depth discussions on advanced findings, recent developments, molecular tumor board, challenging cases within APBCS.

APBCS 2025 promises to be a gathering of minds dedicated to pushing the boundaries of knowledge in the field of Breast Cancer.

We cordially invite you to join us in Singapore, for an invaluable opportunity to learn, network, and collaborate with esteemed colleagues and peers.

Best regards,

APBCS 2025 Committee

Dr. Rebecca Dent | Dr. Shaheenah Dawood | Dr. Lee Soo Chin

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。